Suprachoroidal Triamcinolone Plus Intravitreal Bevacizumab Versus Bevacizumab Alone for Diabetic Macular Edema in Pseudophakic Eyes: A randomized controlled trial
Imran Ahmad, Yousaf Jamal Mahsood · 2026
Read Suprachoroidal Triamcinolone Plus Intravitreal Bevacizumab Versus Bevacizumab Alone for Diabetic Macular Edema in Pseudophakic Eyes: A randomized controlled trial by Imran Ahmad, Yousaf Jamal Mahsood (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13309811.txt.
Description
Imran Ahmad and Yousaf Jamal Mahsood run a randomised trial in 2026 comparing two injection strategies for diabetic macular swelling in eyes that already carry an artificial lens. Eighty-two patients at a Peshawar teaching hospital split evenly between monthly bevacizumab alone and a combined first treatment adding steroid placed behind the eye wall. Vision and macular thickness were measured over four months.
Both groups improved significantly in sight and thickness from their starting points. The combination group finished with better vision scores and a thinner macula than the single-drug group. Its steroid dose was given once, at the first visit, alongside the standard drug. Swelling at the centre of vision is the main sight threat in diabetes, so extra drying power matters. The authors propose the single combined opening treatment as a stronger start for this patient group.
Catalog record
| CREATOR | Imran Ahmad, Yousaf Jamal Mahsood |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |